Advances in non-enzymatic glucose sensors based on metal oxides.
23 Nov 2016-Journal of Materials Chemistry B (The Royal Society of Chemistry)-Vol. 4, Iss: 46, pp 7333-7349
TL;DR: The advances in non-enzymatic glucose sensors based on different metal oxides (such as ZnO, CuO/Cu2O, NiO, Co3O4, MnO2, etc.) and their nanocomposites are summarized and a brief prospective is presented onMetal oxides for glucose sensors.
Abstract: Glucose sensors have been extensively developed because of their broad applications, especially in diabetes diagnosis. Up to date, electrochemical enzymatic glucose sensors are commonly used in daily life for glucose detection and commercially successful as glucose-meters because they exhibit excellent selectivity, high reliability, and could be handled under physiological pH conditions. However, considering some intrinsic disadvantages of enzymes, such as high fabrication cost and poor stability, non-enzymatic glucose sensors have attracted increasing research interest in recent years due to their low cost, high stability, prompt response, and low detection limit. Furthermore, the development of nanotechnology has also offered new opportunities to construct nanostructured electrodes for glucose sensing applications. With distinguished advantages, metal oxides have garnered extensive effort in the development of cost-effective sensors with high stability, sensitivity and quick response for the determination of glucose via electrochemical oxidation. Hence, this review summarizes the advances in non-enzymatic glucose sensors based on different metal oxides (such as ZnO, CuO/Cu2O, NiO, Co3O4, MnO2, etc.) and their nanocomposites. Additionally, a brief prospective is presented on metal oxides for glucose sensors.
Citations
More filters
TL;DR: This review focuses on the newest development in the design of sensing and biosensing platforms based on functional nanomaterials for biological and biomedical applications, which have fascinated the interdisciplinary research arenas spanning chemistry, material science, biological science, and medical industries.
584 citations
Cites background from "Advances in non-enzymatic glucose s..."
...The enhanced catalytic activity is often associated to the synergetic consequence that arises at the boundary of metal and oxide support (Albelda et al., 2017; Zhu et al., 2016)....
[...]
TL;DR: This review of the recent advances on enzymatic and non-enzymatic glucose sensors evolved in the last four years discusses the sensor fabrication methods, the materials and nanostructures involved, the detection principles and the performance of the sensors in whole blood, saliva, urine or interstitial fluids in detail.
236 citations
TL;DR: In this article, the first application of a Co-based porous metal-organic framework (MOF) ZIF-67 as the glucose electrochemical sensor was demonstrated, and the results indicated that with the Ag contents increasing from 0% to 0.5%, the response time of the modified electrode was shorten by more than two times, and sensitivity was increased by two times and a half.
Abstract: In this paper, we demonstrated the first application of a Co-based porous metal-organic framework (MOF) ZIF-67 as the glucose electrochemical sensor. The ZIF-67 modified glassy carbon electrode (GCE) showed an excellent catalytic activity towards glucose oxidation. Meanwhile, to improve the electrocatalytic performance of the modified electrode, a novel Ag@ZIF-67 nanocomposite was fabricated through a sequential deposition-reduction method. The Ag@ZIF-67/GCE exhibited an enhanced catalytic activity towards glucose oxidation. The electrocatalytic performance of Ag@ZIF-67 with different Ag loadings was investigated, and the results indicated that with the Ag contents increasing from 0% to 0.5%, the response time of the modified electrode was shorten by more than two times, and the sensitivity was increased by two times and a half. The Ag-0.5%@ZIF-67GCE exhibited excellent electrocatalytic performances in the glucose concentration range of 2–1000 μM, including a high sensitivity of 0.379 μA μM−1 cm−2, a low detection limit of 0.66 μM (S/N = 3) as well as good selectivity and stability.
197 citations
TL;DR: The detection performances of the graphene-based electrochemical biosensors are in the range of ng/mL and have reached up to fg/mL in detecting the targets of NCDs with higher selectivity, sensitivity and stability with good reproducibility attributes.
162 citations
TL;DR: This review summarizes recent developments of enzyme-free electrochemical and optical glucose sensors, as well as their respective wearable and commercially available devices, capable of detecting glucose at physiological pH conditions without the need to pretreat the biological fluids.
160 citations
References
More filters
TL;DR: Improvement in the design and construction of electrode systems and their associated electronic instrumentation, together with the commercial development and availability of stable amplifiers and recorders, has now provided entirely satisfactory systems for the rapid and accurate measurement of blood pH, pCO2, and pOz.
Abstract: Instruments capable of continuously indicating the chemical composition of blood have proved to be useful in controlling heart-lung machines, in regulating operative and postoperative management of patients, and in teaching and research. At first, such instruments were used with sensors mounted directly in the extracorporeal blood circuit that is used for perfusion of open-heart surgery patients.] Later, continuous monitoring of both machine and patients was conducted by means of continuous withdrawal of blood pumped into external cuvettes equipped with appropriate sensors. Improvement in the design and construction of electrode systems and their associated electronic instrumentation, together with the commercial development and availability of stable amplifiers and recorders, has now provided entirely satisfactory systems for the rapid and accurate measurement of blood pH, pCO2, and pOz. Electrodes for measurement of blood p 0 2 and $ 0 2 can also be used for recording these tensions in gases. By mixing blood with certain reagents, these electrodes can be used to record blood gas contents as well as tensions. Intravascular electrodes are being used to time hydrogen appearance, to detect changes in oxygen tension, and to record ascorbate indicator dilution curves. Such electrodes are proving valuable in cardiac catheterization and in evaluation of the effectiveness of corrective endocardiac surgical procedures. Speed of response, ease of use, autoclavability, smallness of size, and the practicability of using multiple electrodes simultaneously is often sufficient advantage to overcome the present lack of quantitative response of these relatively simple electrodes. By withdrawing blood through microcatheters, continuous recording of blood composition for many hours, even days, is possible, using only about 10 cc. of blood per hr. Continued development of electrode systems may extend their usefulness to the measurement of blood ions, sugar, and urea and finally result in instruments with which analyses can be performed with a minimum of reagents and with but little delay. Electrode systems readily lend themseIves to either intermittent, semiautomatic, or continuous analytical processes. Blood oxygen tension. Electrodes available at present, mounted in thermostated cuvettes, have proved very satisfactory for the measurement of p 0 2 in blood samples. Thousands of analyses have been performed with the several units available here. We have evaluated several means of utilizing electrodes to follow blood pO2 under conditions encountered in cardiovascular operating rooms and have found that analysis of individual samples, withdrawn in plastic syringes, is the least troublesome and most
3,207 citations
TL;DR: The major factors that play a role in the development of clinically accurate in-vivo glucose sensors include issues related to biocompatibility, miniaturization, long-term stability of the enzyme and transducer, oxygen deficit, short stabilization times, in- vivo calibration, baseline drift, safety, and convenience.
Abstract: First-generation glucose biosensors relied on the use of the natural oxygen cosubstrate and the production and detection of hydrogen peroxide and were much simpler, especially when miniaturized sensors are concerned. More sophisticated bioelectronic systems for enhancing the electrical response, based on patterned monolayer or multilayer assemblies and organized enzyme networks on solid electrodes, have been developed for contacting GOx with the electrode support. Electrochemical biosensors are well suited for satisfying the needs of personal (home) glucose testing, and the majority of personal blood glucose meters are based on disposable (screen-printed) enzyme electrode test strips, which are mass produced by the thick film (screen-printing) microfabrication technology. In the counter and an additional “baseline” working electrode, various membranes (mesh) are incorporated into the test strips along with surfactants, to provide a uniform sample coverage. Such devices offer considerable promise for obtaining the desired clinical information in a simpler, user-friendly, faster, and cheaper manner compared to traditional assays. Continuous ex-vivo monitoring of blood glucose was proposed in 1974 and the majority of glucose sensors used for in-vivo applications are based on the GOx-catalyzed oxidation of glucose by oxygen. The major factors that play a role in the development of clinically accurate in-vivo glucose sensors include issues related to biocompatibility, miniaturization, long-term stability of the enzyme and transducer, oxygen deficit, short stabilization times, in-vivo calibration, baseline drift, safety, and convenience.
2,924 citations
TL;DR: In the present review an attempt has been made to describe the salient features of conducting polymers and their wide applications in health care, food industries, environmental monitoring etc.
1,509 citations
TL;DR: The 3D graphene/Co(3)O(4) composite was used as the monolithic free-standing electrode for supercapacitor application and for enzymeless electrochemical detection of glucose and it is demonstrated that it is capable of delivering high specific capacitance and detecting glucose with a ultrahigh sensitivity.
Abstract: Using a simple hydrothermal procedure, cobalt oxide (Co3O4) nanowires were in situ synthesized on three-dimensional (3D) graphene foam grown by chemical vapor deposition. The structure and morphology of the resulting 3D graphene/Co3O4 composites were characterized by scanning electron microscopy, transmission electron microscopy, X-ray diffraction, and Raman spectroscopy. The 3D graphene/Co3O4 composite was used as the monolithic free-standing electrode for supercapacitor application and for enzymeless electrochemical detection of glucose. We demonstrate that it is capable of delivering high specific capacitance of ∼1100 F g–1 at a current density of 10 A g–1 with excellent cycling stability, and it can detect glucose with a ultrahigh sensitivity of 3.39 mA mM–1 cm–2 and a remarkable lower detection limit of <25 nM (S/N = 8.5).
1,467 citations
TL;DR: This chapter should acquaint the reader with the fundamentals of the electrochemistry of glucose and provide a perspective of the evolution of the Electrochemical glucose assays and monitors helping diabetic people, who constitute about 5 % of the world’s population.
Abstract: Over 7,000 peer reviewed articles have been published on electrochemical glucose assays and sensors over recent years. Their number makes a full review of the literature, or even of the most recent advances, impossible. Nevertheless, this chapter should acquaint the reader with the fundamentals of the electrochemistry of glucose and provide a perspective of the evolution of the electrochemical glucose assays and monitors helping diabetic people, who constitute about 5 % of the world’s population. Because of the large number of diabetic people, no assay is performed more frequently than that of glucose. Most of these assays are electrochemical. The reader interested also in nonelectrochemical assays used in, or proposed for, the management of diabetes is referred to a 2007 excellent review of Kondepati and Heise [1].
1,353 citations